Myer Holdings’ stock nosedived on $486 million loss

Myer Holdings’ share price plunged 5.287% to $0.412 today, i.e. 12 September 2018 (1:21 PM AEST), after the company announced disappointing results for the 52 weeks to 28 July 2018.

In FY18 Net Profit after tax of the company has been dragged down to $486 million loss after including one-off items costs of $518.5 million. However, NPAT pre implementation costs and individually significant items was $32.5 million compared to $67.9 million in fiscal year 2017.

Top line has also been shed by 3.2% posting $3.1 billion total sales delivering $149.4 million of earnings before interest tax and amortization. This reflects a 24.6% decline in EBITDA and 137 bps drop in EBITDA margin to 4.82%. Cost of doing business was also up by 1.5% to $1.03 billion.

However, the company reported that subdued sales was partly offset by continued growth in online sales which represents 7.7% of total sales of the company. There have been total online sales of $239.4 million comprising online sales of $192.5 million, up 34.1%, sales by team member on in-store iPads of $30.8 million and online sales for sass & bide, MDL and Myer market. [optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

Recently it has been announced that departmental store Myer (ASX: MYR) has removed 30 senior management and executive roles. Building on this structural change undertaken by the company Myer’s Chairman, Garry Hounsell stated that as it became apparent to the Board that the execution of the strategy will not deliver improved financial performance, we underwent significant leadership changes. The management restructuring has resulted into the exit of Myer’s General Manager of marketing and customer, Ms. Louise Pearson, along with other senior roles. It was said to be in favor of getting closer to the customers.

No dividend has been recognized for the 52 weeks ended 28 July 2018.

The company is expected to launch new website by September 2018 which can potentially boost the online sales of the company.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report